Schedule 13G ownership disclosure

Ventyx Biosciences Inc

Common Stock · CUSIP: 92332V107

Event date: 2025-09-30

Filing-level shares
3,769,997
Percent of class
5.28%
  • The Vanguard Group

    Shares: 3,769,997 · Class: 5.28%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000102909-25-000314
Form type
SCHEDULE 13G
Filer
VANGUARD GROUP INC
CIK
CIK 102909
Filed
Oct 31, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub